Pros | ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | 6/8 | 1/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 12 Years | ||
Fund Size | 1057 Cr | 3313 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹500 Lumpsum ₹5000 | ||
Expense Ratio | 1.23% | 0.97% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | S&P BSE Healthcare PR | S&P BSE Healthcare PR |
No of Holdings | 45 | 32 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (10.93%) Cipla Ltd (6.19%) Dr Reddy's Laboratories Ltd (4.57%) Ajanta Pharma Ltd (4.43%) Glenmark Pharmaceuticals Ltd (3.74%) | Sun Pharmaceuticals Industries Ltd (13.47%) Max Healthcare Institute Ltd Ordinary Shares (6.5%) Divi's Laboratories Ltd (6.2%) Cipla Ltd (5.1%) Lonza Group Ltd ADR (5%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (98.66%) Basic Materials (1.34%) | Health (92.92%) Basic Materials (7.08%) Government (3.05%) | ||
Equity % | 99.55% | 97.29% | ||
Debt % | - | 0.09% | ||
P/E | 34.67 | 42.21 | ||
P/B | 5.43 | 5.85 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 6.66% | 7.45% | ||
3-Month Return | -9.76% | -5.64% | ||
6-Month Return | -8.63% | -1.52% | ||
1-Year Return | 18.18% | 21.09% | ||
3-Year Return | 20.13% | 24.2% | ||
5-Year Return | 28.62% | 30.72% |
Sharpe | 0.84 | 1.12 | ||
Alpha | 1.26 | 5.03 | ||
Beta | 0.96 | 0.85 | ||
Standard Deviation | 16.7 | 14.93 | ||
Information Ratio | 0.31 | 1 |
Description | UTI Healthcare Fund-Growth Option- Direct is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | - | Tanmaya Desai |